X-linked adrenoleukodystrophy and primary adrenal insufficiency.
Cappa M, Todisco T, Bizzarri C.
Front Endocrinol (Lausanne). 2023 Nov 16;14:1309053. doi: 10.3389/fendo.2023.1309053. eCollection 2023.
PMID:38034003
Adrenoleukodystrophy.
Cappa M, Bizzarri C, Vollono C, Petroni A, Banni S.
Endocr Dev. 2011;20:149-160. doi: 10.1159/000321236. Epub 2010 Dec 16.
PMID:21164268
X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.
Engelen M, Kemp S, de Visser M, van Geel BM, Wanders RJ, Aubourg P, Poll-The BT.
Orphanet J Rare Dis. 2012 Aug 13;7:51. doi: 10.1186/1750-1172-7-51.
PMID:22889154
Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy.
Golse M, Weinhofer I, Blanco B, Barbier M, Yazbeck E, Huiban C, Chaumette B, Pichon B, Fatemi A, Pascual S, Martinell M, Berger J, Perlbarg V, Galanaud D, Mochel F.
Brain. 2024 Oct 3;147(10):3344-3351. doi: 10.1093/brain/awae169.
PMID:38832897
The neuropsychiatry of adult-onset adrenoleukodystrophy.